Revolution Medicines, Inc. (RVMDW) Shareholders’ equity 2018–2025
Revolution Medicines, Inc. (RVMDW) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.6BFY2025 · since FY2018: -$108.4M → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6B | -28.0% |
| FY2024 | $2.3B | +24.0% |
| FY2023 | $1.8B | +166.5% |
| FY2022 | $685.2M | +13.7% |
| FY2021 | $602.6M | +26.9% |
| FY2020 | $474.7M | +411.1% |
| FY2019 | -$152.6M | -40.7% |
| FY2018 | -$108.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating marginRVMDW Operating cash flowRVMDW Free cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW overview →